Related Experiment Video
Updated: Jun 27, 2026
11:39
The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
Published on: July 11, 2013
Controversies in Increasing the Pipeline for Pediatric Dermatology
Mollie Oudenhoven1, Jennifer Fernandez2, Nicole Harter1
1Division of Pediatric Dermatology, University of Nebraska Medical Center, Children's Nebraska, Omaha, NE, USA.
Pediatric Clinics of North America
|June 25, 2026
Summary
The pediatric dermatology workforce faces a critical shortage due to training barriers. Innovative solutions and enhanced support are needed to increase the number of specialists for growing demand.
Area of Science:
- Medical Education
- Pediatric Dermatology
- Workforce Development
Background:
- Growing demand for pediatric dermatology services contrasts with a critical shortage of specialists.
- Existing training pathways present significant barriers, including limited early exposure and high costs.
Purpose of the Study:
- To identify barriers contributing to the pediatric dermatology workforce shortage.
- To propose innovative training models and actionable strategies to expand the workforce.
Main Methods:
- Analysis of current training pathways and identified barriers.
- Proposal of new residency tracks, combined programs, and enhanced support systems.
Main Results:
- Key barriers include insufficient early exposure, lack of mentorship, and lengthy, expensive training.
- Proposed solutions involve streamlining training, increasing educational resources, and providing institutional support.
Conclusions:
- Addressing the pediatric dermatology workforce shortage requires innovative training models and collaborative efforts.
- Actionable strategies, such as mandatory exposure and increased preliminary positions, are crucial for increasing the number of practicing pediatric dermatologists.
Related Concept Videos
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
01:29Drug Dosing: Infants and Children
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
01:27Acne Infection
Acne is a multifactorial skin condition primarily affecting adolescents and young adults, with a global prevalence estimated to exceed 75% in this demographic. The condition is characterized by the formation of comedones (blackheads and whiteheads), papules, pustules, nodules, and, in severe cases, cysts, particularly in areas rich in sebaceous glands such as the face, neck, chest, and back. The pathogenesis involves increased sebum production, follicular hyperkeratinization, colonization by...